Back to mobile site

Form SCHEDULE 13G/A Qualigen Therapeutics, Filed by: ALPHA CAPITAL ANSTALT

November 12, 2025 5:18 PM EST





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Note to 5, 7, 9 and 11: Based on 1,695,450 shares outstanding as of September 22, 2025 as reported on DEF-14A filed with the Securities and Exchange Commission on October 20, 2025.


SCHEDULE 13G



 
Alpha Capital Anstalt
 
Signature:/s/ Konrad Ackermann
Name/Title:Konrad Ackermann/Director
Date:11/12/2025


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G